Eversana, a provider of 'next-generation' commercial services to the global life sciences industry, has named Sy Pretorius as the company’s new Chief Operating Officer and President, Outsourced Solutions.
Described as a highly regarded leader in clinical development and commercial operations, Pretorius joins Eversana with more than 25 years of life sciences experience including multiple executive advisory roles, most recently serving as President, Clinical Development and Chief Medical Officer, at Parexel.
He will be responsible for driving operational excellence across the company’s growing outsourced operations including Channel Management, Compliance Services, Field Deployment Solutions and Patient Services, as well as critical infrastructure teams including Information Technology and Business Transformation.
Pretorius joins Eversana as it rapidly expands its global commercialization services. Since its launch in 2018, EVERSANA created the industry’s first fully integrated outsourced service model, from just over 1,000 employees in 2018 to nearly 7,000 today across 16 countries.
Pretorius, a trained physician with master’s degrees in Pharmacology, Business Administration, and Drug Development, is a recognized thought leader across the pharmaceutical industry. He is an honorary Fellow of the Faculty of Pharmaceutical Medicine (FFPM) in the United Kingdom and teaches drug development at several institutions including Harvard Medical School. He was named to the PharmaVOICE 100 list in 2017.